Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Pfizer, Inc. et al v. Apotex Inc. et al
Case Number:
1:10-cv-05272
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
October 04, 2011
Relpax Patent Fight Revived After Stalled Settlement
A New York federal judge on Tuesday reopened Pfizer Inc.'s patent infringement suit against Apotex Inc. over the company's plan to sell a generic version of the migraine drug Relpax, after a proposed settlement fell through.
-
July 27, 2011
Pfizer, Apotex To End Fight Over Generic Relpax
Pfizer Inc. notified a New York federal judge Tuesday that it was close to settling a patent infringement suit over rival Apotex Inc.'s plan to sell a generic version of the migraine drug Relpax.